Page last updated: 2024-08-05 10:43:57

chalcones

A ketone that is 1,3-diphenylpropenone (benzylideneacetophenone), ArCH=CH(=O)Ar, and its derivatives formed by substitution.

ChEBI ID: 23086

Members (52)

MemberDefinitionRole
1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one
1-phenyl-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one1-phenyl-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one
2,4,2',4'-Tetrahydroxychalcone2,4,2',4'-Tetrahydroxychalcone
2'-hydroxychalconeA member of the class of chalcones that is trans-chalcone substituted by a hydroxy group at position 2'.2'-hydroxychalcone
2',3,4-trihydroxychalconeA member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 2', 3 and 4. The precursor of 3',4'-dihydroxyaurone.2',3,4-trihydroxy-trans-chalcone
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalconeA member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 2' and 4', a methoxy group at position 6' and methyl groups at positions 3' and 5'. Isolated from the buds of Cleistocalyx operculatus, it has been shown to exhibit inhibitory effects on the viral neuraminidases from two influenza viral strains, H1N1 and H9N2.2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone
2',4',6'-trihydroxychalconeA member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 2', 4' and 6' respectively.pinocembrin chalcone
2',4',6'-Trihydroxydihydrochalcone2',4',6'-Trihydroxydihydrochalcone
2',5'-dihydroxychalcone2',5'-Dihydroxychalcone
2',6'-dihydroxy-4'-methoxychalconePinostrobin chalcone
3-deoxysappanchalconeA member of the class of chalcones that is isoliquiritigenin in which one of the hydroxy groups at position 2' is replaced by a methoxy group.2'-O-methylisoliquiritigenin
3-hydroxyphloretin3-Hydroxyphloretin
3-o-methylbuteinHomobutein
4-chlorochalconeA member of the class of chalcones that is trans-chalcone substituted by a chloro group at position 4.4-chlorochalcone
4-hydroxychalconeA member of the class of chalcones that is trans-chalcone substituted by a hydroxy group at position 4.4-hydroxychalcone
4-hydroxycordoinA member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at position 4 and 2' and a (3-methylbut-2-en-1-yl)oxy group at position 4'. It has been isolated from Lonchocarpus neuroscapha.4-hydroxycordoin
4-hydroxyderricin4-Hydroxyderricin
4-Methoxylonchocarpin4-Methoxylonchocarpin
4'-hydroxychalconeA member of the class of chalcones that is trans-chalcone substituted by a hydroxy group at position 4'.4'-hydroxychalcone
4'-methoxychalcone4'-Methoxychalcone
bavachalconeBavachalcone
buteinA chalcone that is (E)-chalcone bearing four additional hydroxy substituents at positions 2', 3, 4 and 4'.butein
calythropsinCalythropsin
cardamoninCardamonin
CrotaoprostrinCrotaoprostrin
derricidinDerricidin
flavokawain aFlavokawain A
flavokawain bA member of the class of chalcones that consists of trans-chalcone substituted by hydroxy group at positions 2' and methoxy groups at positions 4' and 6'. Isolated from Piper methysticum and Piper rusbyi, it exhibits antileishmanial, anti-inflammatory and antineoplastic activities.flavokawain B
flavokawain Cflavokawain C
helichrysetinHelichrysetin
isobavachalconeA member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 4, 2' and 4' and a prenyl group at position 3'.isobavachalcone
isobutrinA member of the class of chalcones that is trans-chalcone substituted by beta-D-glucopyranosyloxy groups at positions 3 and 4' and hydroxy groups at positions 4 and 2' respectively.isobutrin
isocordoinIsocordoin
isoliquiritigeninA member of the class of chalcones that is trans-chalcone hydroxylated at C-2', -4 and -4'.isoliquiritigenin
Isoliquiritigenin 4,4'-dimethyl etherIsoliquiritigenin 4,4'-dimethyl ether
isosalipurposideA monosaccharide derivative that is trans-chalcone substituted by hydroxy groups at positions 4, 4' and 6 and a beta-D-glucopyranosyloxy group at position 2' respectively.phlorizin chalcone
Kanzonol BKanzonol B
licochalcone aLicochalcone A
licochalcone bLicochalcone B
linderol a(-)-Linderol A
LonchocarpinLonchocarpin
morachalcone aMorachalcone A
myrigalone bMyrigalon B
naringenin chalconeA member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 2' ,4, 4', and 6' respectively.2',4,4',6'-tetrahydroxychalcone
okaninA member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 3, 4, 2', 3', and 4' respectively.okanin
perflubronA member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 4, 2', 4', and 6' and a 3-methylbut-2-en-1-yl group at position 3'.desmethylxanthohumol
sappanchalconeA member of the class of chalcones that consists of trans-chalcone substituted by hydroxy groups at positions 3, 4 and 4' and a methoxy group at position 2'. Isolated from Caesalpinia sappan, it exhibits neuroprotective and cytoprotective activity.sappanchalcone
sofalconeA member of the class of chalcones that is benzene in which the hydrogens at positions 1,2 and 5 are replaced by carboxymethoxy, (1E)-1-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-3-oxoprop-1-en-3-yl, and (3-methylbut-2-en-1-yl)oxy groups, respectively. It is a gastrointestinal drug currently used for treatment of gastritis and gastric ulcers in Japan and South Korea.sofalcone
UvangoletinUvangoletin
Xanthoangelol DXanthoangelol D
xanthohumolA member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 4, 2' and 4', a methoxy group at position 6' and a prenyl group at position 3'. Isolated from Humulus lupulus, it induces apoptosis in human malignant glioblastoma cells.xanthohumol
xanthohumol cXanthohumol C

Research

Studies (1,992)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-199039 (1.96)18.7374
1990's94 (4.72)18.2507
2000's375 (18.83)29.6817
2010's1,059 (53.16)24.3611
2020's425 (21.34)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials30 (1.26%)5.53%
Reviews110 (4.63%)6.00%
Case Studies1 (0.04%)4.05%
Observational0 (0.00%)0.25%
Other2,233 (94.06%)84.16%